PARIS — The oral multiple sclerosis (MS) drug fingolimod (Gilenya, Novartis) has shown impressive results in the pediatric population, with large reductions in relapse rate, new MRI lesions, brain ...

BUFFALO, N.Y. -- A study by researchers in the University at Buffalo's Pediatric Multiple Sclerosis Center of Excellence has produced the first examination of deficits in pediatric patients with ...

BUFFALO, N.Y. -- The Jacobs Neurological Institute of the University at Buffalo has received a $1.8 million, five-year grant from the National Multiple Sclerosis Society to establish at Women & ...

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, discusses the current body of data on treating pediatric multiple sclerosis (MS) ...

University of Alabama at Birmingham (UAB) School of Nursing Instructor Yolanda Wheeler, MSN, CRNP, CPNP-AC, wants to know how Multiple Sclerosis (MS) impacts decision-making in children. Using a ...

MS usually strikes women in their mid-30s or 40s Only about 8%2C000 children have the disease worldwide Drug companies are poised to begin the first clinical trials in children BOSTON — Two years ago, ...

NEW YORK, NY... 'Pediatric Multiple Sclerosis and Related Disorders' has just been published by the International Pediatric MS Study Group as a supplement to the journal Neurology. The Group was ...

ORLANDO — New research suggests that continual eye problems after demyelination isn't reserved for adults with MS only, as youth are also affected. A prospective comparison study of more than 100 ...

Please provide your email address to receive an email when new articles are posted on . The 2-year follow-up also showed similar findings in adults with MS, O’Neill, a pediatric neuroimmunology fellow ...

“For the first time, we have an FDA-approved treatment specifically for children and adolescents with multiple sclerosis,” explains Billy Dunn, M.D., director of the Division of Neurology Products in ...

Demyelinating disease, including multiple sclerosis and neuromyelitis optica, can affect children and teens. Our program works closely with the Multiple Sclerosis Program at University of Utah ...

Pediatric-onset MS requires specialized care due to unique clinical features like cognitive issues and motor impairment. Unstructured transitions from pediatric to adult care lead to treatment delays, ...